High TPMT activity as a risk factor for severe myelosuppression during thiopurine therapy

M.L. Seinen, A.A. van Bodegraven, A.B.P. van Kuilenburg, K.H.N. de Boer

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)222-223
JournalNetherlands Journal of Medicine
Volume71
Issue number4
Publication statusPublished - 2013

Cite this